Jan. 11, 2024
by Michael Whitworth, Trevor Hutchings, Alex Jones
Biopharma insight
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
Jan. 10, 2024
by Emma Banks
Biopharma insight
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside …
March 18, 2024
by Irina Bilous
Biopharma insight
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …
Feb. 23, 2024
by Andrii Buvailo, PhD
Interview
In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …
March 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial …
Jan. 30, 2024
by Andrii Buvailo, PhD
Biopharma insight
Covid 19 pandemic that we went through revealed the fragility of our world. Despite the undeniable technological advancements of the …
Feb. 5, 2024
by Marco Schmidt
Biopharma insight
The term "Innovator's Dilemma" was coined by Clayton Christensen in 1997. The Innovator's Dilemma refers to a situation where successful, …
Dec. 20, 2023
by Dr. Khalid Fakhro
Biopharma insight
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Jan. 28, 2024
by Andrii Buvailo, PhD
News
A new mission aboard SpaceX CRS-29, launching from NASA's Kennedy Space Center in Cape Canaveral, Florida, on January 30, 2024, …
April 3, 2024
by BiopharmaTrend
News
In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade …
Jan. 24, 2024
by Andrii Buvailo
Biopharma insight
According to a 2023 Deloitte report, "Sizing the Brain," by Álvaro Nuño Pérez, Jose M Suárez, and Michel LE BARS, providing an in-depth analysis of …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …